By Dr. Ross Feldman,
Medical Lead,
Cardiac Sciences Manitoba

February 09, 2020

This Week!

The Manitoba Association of Cardiology Technologists along with the Canadian Society of Cardiology Technologists celebrates Cardiology Technology Day on February 14th! It is also the 50th Anniversary for the CSCT this year, We would like to take this opportunity to recognize the excellence in service provided by our Registered Cardiology Technologists in performing EKGs, Stress Testing, Holter/Event/Ambulatory Blood Pressure Monitoring and assistance with other cardiac procedures in the Cardiac Sciences Program in the City of Winnipeg and across the Province of Manitoba.


On Wednesday February 12th from 12:00 PM-1:00 PM in the Sam Cohen Auditorium, there will be a presentation by Mahwash Saeed, Olga Toleva and Ludolf Grolle entitled: Breaking the Cycle: Heart Disease throughout the Lifespan. Also, from 1:30 PM-4:00 PM, the Art and Soul Exhibition will take place in the Asper Mezzanine.

On Thursday February 13th from 6:30 PM-8:30 PM, at the Reh-Fit Centre- 1390 Taylor Avenue, there will be a public talk entitled: There is More to Watch for than “Chest Pain”.

For more information please visit:

Publications by our Faculty this Week

Boreskie KF, Oldfield CJ, Hay JL, Moffatt TL, Hiebert BM, Arora RC, Duhamel TA. Myokines as biomarkers of frailty and cardiovascular disease risk in females. Exp Gerontol. 2020 Feb 1:110859. doi: 10.1016/j.exger.2020.110859. [Epub ahead of print]

Wiens EJ, Arbour J, Thompson K, Seifer CM. Routine creatine kinase testing does not provide clinical utility in the emergency department for diagnosis of acute coronary syndromes. BMC Emerg Med. 2019 Jul 9;19(1):37. doi: 10.1186/s12873-019-0251-4.

Manji RA, Manji JS. Studying Xenograft Rejection of Bioprosthetic Heart Valves. Methods Mol Biol. 2020;2110:227-243. doi: 10.1007/978-1-0716-0255-3_15.

Zhu A, Bews H, Cheung D, Nagalingam RS, Mittal I, Goyal V, Asselin C, Kirkpatrick I, Czubryt MP, Jassal DS. Scleraxis as a Prognostic Marker of Myocardial Fibrosis in Hypertrophic Cardiomyopathy (SPARC) Study. Can J Physiol Pharmacol. 2020 Feb 6. doi: 10.1139/cjpp-2019-0636. [Epub ahead of print]